RhumbLine Advisers’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q2
Sell
-16,074
Closed 3082
2019
Q1
$0 Sell
16,074
-302,717
-95% ﹤0.01% 2975
2018
Q4
$36K Buy
318,791
+97,448
+44% +$11K ﹤0.01% 2962
2018
Q3
$376K Sell
221,343
-16,175
-7% -$27.5K ﹤0.01% 2393
2018
Q2
$413K Buy
237,518
+14,845
+7% +$25.8K ﹤0.01% 2388
2018
Q1
$407K Buy
222,673
+5,080
+2% +$9.29K ﹤0.01% 2293
2017
Q4
$485K Sell
217,593
-41,815
-16% -$93.2K ﹤0.01% 2244
2017
Q3
$752K Buy
259,408
+3,490
+1% +$10.1K ﹤0.01% 2123
2017
Q2
$1.14M Buy
255,918
+34,942
+16% +$156K ﹤0.01% 1882
2017
Q1
$1.03M Buy
220,976
+20,900
+10% +$97.4K ﹤0.01% 1892
2016
Q4
$1.22M Buy
200,076
+17,847
+10% +$109K ﹤0.01% 1748
2016
Q3
$1M Buy
182,229
+15,800
+9% +$87.1K ﹤0.01% 1798
2016
Q2
$632K Buy
166,429
+69,265
+71% +$263K ﹤0.01% 2049
2016
Q1
$268K Buy
97,164
+1,290
+1% +$3.56K ﹤0.01% 2589
2015
Q4
$544K Buy
95,874
+7,005
+8% +$39.7K ﹤0.01% 2193
2015
Q3
$471K Buy
88,869
+3,236
+4% +$17.2K ﹤0.01% 2265
2015
Q2
$711K Sell
85,633
-10,605
-11% -$88.1K ﹤0.01% 2096
2015
Q1
$445K Buy
96,238
+17,700
+23% +$81.8K ﹤0.01% 2362
2014
Q4
$240K Buy
78,538
+2,275
+3% +$6.95K ﹤0.01% 2700
2014
Q3
$212K Buy
76,263
+4,200
+6% +$11.7K ﹤0.01% 2718
2014
Q2
$293K Buy
72,063
+4,504
+7% +$18.3K ﹤0.01% 2613
2014
Q1
$359K Sell
67,559
-4,921
-7% -$26.2K ﹤0.01% 2422
2013
Q4
$402K Sell
72,480
-710
-1% -$3.94K ﹤0.01% 2390
2013
Q3
$330K Sell
73,190
-345
-0.5% -$1.56K ﹤0.01% 2468
2013
Q2
$313K Buy
+73,535
New +$313K ﹤0.01% 2601